Clinical Trial Update: A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects [Phase 1, Phase 2]

View source ↗

Summary

This update summarizes the completed Phase 1/2 trial of a dendritic cell vaccine in HIV-1 infected subjects, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV-1 Infection, HIV Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-03-08